The Board

The Board

Johan Bygge

Johan Bygge

Chairman of the board

Chairman of the board since May 2021. Johan Bygge holds a Master of Science from Stockholm School of Economics.

Previous experience: Chairman of EQT Asia Pacific, COO EQT, CFO Investor AB, Deputy CEO Electrolux, CFO Electrolux. Board member of Anticimex, PSM Ltd, I-Med, ILA Vietnam, Sanitec Oy, Hi3G Scandinavia, Rådet för god sed på Aktiemarknaden, etc.

Other assignments: Chairman of the board of Nobina AB (publ) and Scandi Standard AB (publ). Board member of Getinge AB, Capman Plc, Lantmännen ek för, Praktikertjänst and Tredje AP-fonden (AP3). SNS Förtroenderåd etc.

Shareholding: -

Independent in relation to the company and its senior management as well as to its major shareholders.

Goran Forsberg 1 1

Göran Forsberg

Member of the board

Board member since May 2019. Born 1963. Göran Forsberg is a PhD in Biochemistry and Associate Professor.

Previous experience: Göran Forsberg has more than 30 years of experience from pharmaceutical development in both the Biotech industry and in large pharmaceutical companies. He has extensive experience of many different parts of drug development, as well as business development and investor relations. Göran Forsberg is the CEO of Cantargia AB since 2014. Prior to that, he worked as a business development manager at Active Biotech. Previous experience comes from positions at Pharmacia, KabiGen and the University of Adelaide in Australia. Board member of Isogenica Ltd.

Other assignments: Göran Forsberg is CEO of Cantargia AB since 2014.

Shareholding: 40,912 shares

Independent in relation to the company and its senior management as well as to its major shareholders.

Pia Gideon

Pia Gideon

Member of the board

Board member since May 2021. Pia Gideon holds a Master of Science from Stockholm School of Economics.

Previous experience: 20 years of experience as a board member and chairman of listed companies as well as startups and state-owned companies. Held various positions within Ericsson, including marketing manager in North America. Pia Gideon also has a background as financial analyst and financial journalist.

Other assignments: Chairman of the board of Klövern AB and Qlucore AB. Board member of Apoteket AB, Gideon & Partners AB and Metria AB.

Shareholding: -

Independent in relation to the company and its senior management as well as to its major shareholders.

J hulthe1

Johannes Hulthe

Member of the board

Board member since May 2019. Born 1970. Johannes Hulthe is a PhD and MSc in Economics.

Previous experience: Johannes Hulthe has more than 17 years of experience from the pharmaceutical industry. Lecturer in cardiovascular prevention at Sahlgrenska University Hospital, Gothenburg. Johannes Hulthe was under 13 years employed at AstraZeneca and, when he finished in 2014, held the role of chief (vice president) in clinical drug development for heart vessels, metabolism and kidney disease.

Other assignments: Co-founder, CEO and board member of Antaros Medical AB, board member of Antaros Holding AB, chairman of Antaros Renostic AB.

Shareholding: -

Independent in relation to the company and its senior management as well as to its major shareholders.

Lars hockenstrom

Lars Höckenström

Member of the board

Board member since October 2019. Born 1956. Lars Höckenström holds an MBA from Stockholm University.

Previous experience: Lars Höckenström has more than 35 years of finanical experience as an advisor in private and public transactions such as IPOs, rights issues and private placements within a broad range of sectors. Lars was a co-founder and Partner at Aragon Fondkommission AB, financial analyst at Öhman Fondkommission AB, Head of Research at Matthew Fondkommission AB, investment manager at Core Ventures, analyst and fund manager at Catella Kapitalförvaltning AB and analyst and corporate finance at Paretos Securities. He was also co-founder and Senior Advisor at Naventus Corporate Finance AB.

Other assignments: Board member of Devyser Holding AB, AB Consiliario and Klövern AB. Deputy board member of Gårdarike Fastigheter AB, Gårdarike Invest Aktiebolag and Gårdarike AB.

Shareholding: 20,000 shares

Independent in relation to the company and its senior management as well as to its major shareholders.